Contact Sales

-23rd October 2014

£110m research centre in cancer medicine to be established at Oxford University

New institute will include research on the use of proton beam therapy A £110m cancer research institute is to be established at Oxford University, a development spurred by a £35m grant from the UK government.

The Precision Cancer Medicine Institute will carry out research into a wide range of cancer therapies, including the use of genomics and molecular diagnostics, advanced cancer imaging, trials of new drugs, minimally invasive surgery and proton beam therapy.

The aim is to understand how making cancer treatments less invasive and more directed to the characteristics of the patient’s own tumour could improve cure rates.

Scientists will now work to establish the new institute with a £35m grant from the Higher Education Funding Council for England (Hefce) through its UK Research Partnership Investment Fund (RPIF). This is to be matched with over £75 million of investment in financial contributions and support in kind from partners in the project.

The proposed partners include Cancer Research UK; Roche Diagnostics; GE Healthcare; Mirada Medical; Brandon Medical; Blue Earth Diagnostics; and the University of Florida Health Proton Therapy Institute.   Click here for the full press release.